Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006800HBVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30084720HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30063823HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30063824HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS30063825HIVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS20060150HPVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS20059200HPVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TVIS20018080HPVENSG00000145888.11protein_codingGLRA1NoNo2741P23415
Q14C71
TCGA Plot Options
Drug Information
GeneGLRA1
DrugBank IDDB09061
Drug NameCannabidiol
Target IDBE0004857
UniProt IDP48167
Regulation Typeallosteric modulator
PubMed IDs26264914; 19204413
CitationsIbeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ: Molecular Targets of Cannabidiol in Neurological Disorders. Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3.@@Ahrens J, Demir R, Leuwer M, de la Roche J, Krampfl K, Foadi N, Karst M, Haeseler G: The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function. Pharmacology. 2009;83(4):217-22. doi: 10.1159/000201556. Epub 2009 Feb 10.
GroupsApproved; Investigational
Direct ClassificationAromatic monoterpenoids
SMILESCCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
Pathways
PharmGKB
ChEMBLCHEMBL190461